MET oncogene in non-small cell lung cancer: mechanism of MET dysregulation and agents targeting the HGF/c-Met axis

H Liang, M Wang - OncoTargets and therapy, 2020 - Taylor & Francis
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide
and has a poor prognosis. Current treatments for advanced NSCLC included traditional …
被引用次数：101 相关文章

MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis.

H Liang, M Wang - Oncotargets and Therapy, 2020 - europepmc.org
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide
and has a poor prognosis. Current treatments for advanced NSCLC included traditional …

[引用][C] MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis

H Liang, M Wang - OncoTargets and Therapy, 2020 - cir.nii.ac.jp
<p>MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and
Agents Targeting the HGF/c-Met Axis</p> | CiNii Research CiNii 国立情報学研究所 学術情報 …
[HTML] nih.gov

[HTML][HTML] MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis

H Liang, M Wang - OncoTargets and therapy, 2020 - ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide
and has a poor prognosis. Current treatments for advanced NSCLC included traditional …

MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis

H Liang, M Wang - OncoTargets and Therapy, 2020 - dovepress.com
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide
and has a poor prognosis. Current treatments for advanced NSCLC included traditional …

MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis

H Liang, M Wang - OncoTargets and therapy, 2020 - pubmed.ncbi.nlm.nih.gov
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide
and has a poor prognosis. Current treatments for advanced NSCLC included traditional …

MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis.

H Liang, M Wang - OncoTargets & Therapy, 2020 - search.ebscohost.com
Non-small cell lung cancer (NSCLC) is the leading cause of cancer-related death worldwide
and has a poor prognosis. Current treatments for advanced NSCLC included traditional …